Several recent Congressional hearings have focused on health policy issues. For instance, the House Energy and Commerce Committee held hearings on Food and Drug Administration regulation of over-the-counter drugs and Public Health Service Act health workforce programs.
The Senate Finance Committee held hearings on the Graham-Cassidy health insurance reform bill, CHIP funding reauthorization, and health care costs and insurance coverage. The Senate Committee on Health, Education, Labor, and Pensions held a series of bipartisan hearings to get feedback from stakeholders on ways to stabilize and strengthen the individual health insurance markets. The panel also has scheduled an October 5, 2017 hearing on the federal response to the opioid crisis.
This article is presented for informational purposes only and is not intended to constitute legal advice.
